KYOTO PREFECTURAL UNIVERSITY OF MEDICINE
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1921-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
253
Active:1
Completed:139
Trial Phases
5 Phases
Phase 1:16
Phase 2:12
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (252 trials with phase data)• Click on a phase to view related trials
Not Applicable
216 (85.7%)Phase 1
16 (6.3%)Phase 2
12 (4.8%)Phase 3
4 (1.6%)Phase 4
4 (1.6%)Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Target Recruit Count
- 160
- Registration Number
- NCT03324932
- Locations
- 🇯🇵
Hisako Ono, Kyoto, Japan
Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients
Not Applicable
Terminated
- Conditions
- Acute Myocardial InfarctionAngina PectorisAcute Coronary SyndromeHypertensionMyocardial Ischemia
- Interventions
- Drug: Blopress (Candesartan)
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2015-09-03
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Target Recruit Count
- 1500
- Registration Number
- NCT00863980
- Locations
- 🇯🇵
Shakaihoken Kobe Central Hospital, Kobe, Japan
🇯🇵Akashi Municipal Hospital, Kobe, Japan
🇯🇵Kouseikai Takeda Hospital, Kyoto, Japan
Pitavastatin on Carotid Intima-media Thickness
- First Posted Date
- 2008-07-09
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Target Recruit Count
- 300
- Registration Number
- NCT00711919
- Locations
- 🇯🇵
Ayabe City Hospital, Ayabe, Kyoto, Japan
🇯🇵Fukuchiyama City Hospital, Fukuchiyama, Kyoto, Japan
🇯🇵Tanabe Central Hospital, Kyotanabe, Kyoto, Japan
Anti-Restenosis After AMI by Erythropoietin
Phase 4
- Conditions
- Acute Myocardial Infarction
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2007-01-17
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Target Recruit Count
- 72
- Registration Number
- NCT00423020
- Locations
- 🇯🇵
Kyoto Prefectural University of Medicine, Kyoto, Japan
Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
Phase 4
Completed
- Conditions
- HypertensionIschemic Heart DiseaseCongestive Heart FailureStroke
- Interventions
- Drug: Non-ARB
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2012-12-12
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Target Recruit Count
- 3031
- Registration Number
- NCT00149227
- Locations
- 🇯🇵
Kyoto Prefectural University of Medicine, Kyoto, Japan
News
No news found